Herfindahl-Hirschman Index — sum of squared market shares — to measure the concentration of Rx volume across products within each territory. The HHI is a real concentration metric used by FTC for antitrust analysis and by pharma strategy teams to identify where one brand is dominating a local market (high HHI) versus where multiple brands compete (low HHI).